Apotex Selling Shareholders Close C$850 Million Secondary Offering

SK Capital, Sherfam and Allan Oberman sold 25 million Apotex shares at C$34 each, with all proceeds going to the selling shareholders and none to Apotex.

SK Capital, Sherfam and Allan Oberman sold 25 million Apotex shares at C$34 each, with all proceeds going to the selling shareholders and none to Apotex.

The German industrial supplier will acquire 9.3 million shares and cancel them after the residual allocation was about 17 times oversubscribed, completing its planned €260 million capital return tied to the Water Management sale.

Sales volumes also rose 0.9% over the latest three months, while online spending climbed and fuel sales weakened as pump prices rose.

The BOJ lifted its overnight call-rate target by 25 basis points, extending its exit from ultra-low rates even as August core inflation remained below 2%.

The proposed notes would finance remaining construction, reimburse prior CleanSpark equity contributions and fund debt-service reserves for the 175 MW Georgia project.

The AI cloud company is marketing convertible senior notes due 2033, with expected pricing that could bring the total offering to as much as $3.5 billion.

Total residential construction softened in August, but single-family starts rose 7.6% even as permits for future single-family building declined.

New unemployment claims fell by 10,000 in the week ended September 12, while continuing claims dropped to 1.730 million in the latest available week.

The four issuers are among 17 named in Nasdaq’s September 17 delisting notice after their securities had already been suspended for months.

Contract signings improved slightly from July, but all four U.S. regions remained below year-ago levels as mortgage rates continued to constrain housing demand.